↓ Skip to main content

Cardiovascular Events in Patients taking Varenicline

Overview of attention for article published in Drug Safety, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

blogs
1 blog

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
64 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cardiovascular Events in Patients taking Varenicline
Published in
Drug Safety, November 2012
DOI 10.2165/11597690-000000000-00000
Pubmed ID
Authors

Mira Harrison-Woolrych, Simran Maggo, Ming Tan, Ruth Savage, Janelle Ashton

Abstract

The smoking cessation medicine varenicline has been associated with an increased risk of cardiovascular adverse events compared with placebo in clinical trials. Cases of cardiovascular events, including myocardial infarction (MI) and cardiac dysrhythmias, have been noted from spontaneous reporting systems.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Indonesia 1 2%
Denmark 1 2%
Canada 1 2%
Unknown 61 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 17%
Student > Master 7 11%
Student > Bachelor 6 9%
Other 5 8%
Student > Ph. D. Student 4 6%
Other 14 22%
Unknown 17 27%
Readers by discipline Count As %
Medicine and Dentistry 32 50%
Nursing and Health Professions 3 5%
Agricultural and Biological Sciences 3 5%
Social Sciences 3 5%
Sports and Recreations 2 3%
Other 3 5%
Unknown 18 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 January 2012.
All research outputs
#5,327,870
of 25,374,917 outputs
Outputs from Drug Safety
#576
of 1,852 outputs
Outputs of similar age
#50,675
of 285,246 outputs
Outputs of similar age from Drug Safety
#216
of 812 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,852 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 285,246 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 812 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.